Australia TGA ARTG record

Wart cryogenic kit

Australia TGA ARTG Registered Device · Actor Pharmaceuticals Pty Ltd · Medical Brands Innovations BV · Class IIa · Started December 13, 2023

Good Name: Actor Pharmaceuticals Pty Ltd - Wart cryogenic kit

Device classification

Risk Class: Class IIa
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: December 13, 2023
Effective Date: December 13, 2023

Sponsor

Name: Actor Pharmaceuticals Pty Ltd

Manufacturer

Name: Medical Brands Innovations BV
Country: Netherlands
Address: Weesperstraat 114, AP Diemen, 1112

Intended purpose

Excilor Duo Warts Treatment is intended to treat common warts (verruca vulgaris, usually located on hands and feet) and foot warts (verruca plantaris) in adults and children from 4 years old.

About this record

Access comprehensive regulatory information for Wart cryogenic kit in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Actor Pharmaceuticals Pty Ltd, manufactured by Medical Brands Innovations BV in Netherlands. The device registration started on December 13, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.